NGLFINE vs WOCKPHARMA: Stock Comparison

NGL Fine-Chem Limited vs Wockhardt Ltd

Live data: 22 July 2026, 3:05 PM IST • Source: NSE and company filings

Wockhardt Ltd is the larger company by market capitalisation. NGL Fine-Chem Limited shows a lower P/E, a higher ROE and a higher dividend yield. These are relative readings on individual metrics — weigh valuation against growth, margins, leverage and capital efficiency rather than treating any single number as decisive.

Side-by-side comparison of NGL Fine-Chem Limited and Wockhardt Ltd on live price, valuation, growth, profitability, leverage and quarterly shareholding. Highlighted values mark the more favourable of the two on that metric's usual reading; a single metric is never the full story.

On standard readings, NGLFINE is more favourable on 12 of 13 scored metrics and WOCKPHARMA on 1These counts are context-free and are not an overall rating.

Key Differences

Market Cap
WOCKPHARMA is the larger company
₹30,362 Cr vs ₹2,015 Cr
P/E Ratio
NGLFINE has a lower P/E
41.23x vs 144.46x
P/B Ratio
NGLFINE has a lower P/B
6.03x vs 6.23x
EPS
NGLFINE has higher earnings per share
₹78.04 vs ₹13.1
Dividend Yield
NGLFINE has a higher dividend yield
0.05% vs 0%
Revenue Growth (TTM YoY)
NGLFINE has faster revenue growth
57.2% vs 26%
EPS Growth (TTM YoY)
NGLFINE has faster EPS growth
1,539.8% vs 0%
Qtr Sales Growth
NGLFINE has stronger quarterly sales growth
57.1% vs 29.9%

Each difference is a single, relative reading — StockeZee does not name an overall winner.

Profile

MetricNGLFINEWOCKPHARMA
SectorHealthcareHealthcare
IndustryPharmaceuticalsPharmaceuticals

Price

MetricNGLFINEWOCKPHARMA
Live Price₹3,260₹1,865
Day Change0.7%-1.65%
Volume5,5957.27 L
52-Week High₹3,329₹2,422.3
52-Week Low₹1,175.5₹1,086.7
Distance from 52W High-2.07%-23.01%

Valuation

MetricNGLFINEWOCKPHARMA
Market Cap₹2,015 Cr₹30,362 Cr
P/E Ratio41.23x144.46x
P/B Ratio6.03x6.23x
EPS₹78.04₹13.1
Book Value₹532.95₹304
Dividend Yield0.05%0%

Growth

MetricNGLFINEWOCKPHARMA
Revenue Growth (TTM YoY)57.2%26%
EPS Growth (TTM YoY)1,539.8%0%
Qtr Sales Growth57.1%29.9%
Qtr Profit Growth2,398%688%

Profitability & Leverage

MetricNGLFINEWOCKPHARMA
ROE15.7%6.11%
ROCE17%7.55%
Net Margin9.59%3.3%
Operating Margin14.5%19.3%
Debt to Equity0.33x0.45x

Shareholding

As of Mar 2026 • change vs previous quarter
MetricNGLFINEWOCKPHARMA
Promoter Holding72.74%49.08%
FII Holding0.03% 0.03 pp7.09% 0.1 pp
DII Holding0%10.96% 0.41 pp
Public Holding27.24% 0.02 pp32.83% 0.52 pp

How to Read This Comparison

Valuation ratios (P/E, P/B) use the latest consolidated figures where available; growth numbers compare against the same period last year; shareholding percentages come from the most recent quarterly filings, with the change shown against the prior quarter. A "more favourable" highlight is relative between these two companies only — it is not a rating, a recommendation, or a comparison against the wider sector. Rows with no reported data for either company are hidden rather than shown empty.

Deep-dive each company on its stock page for quarterly results, technicals, filings and the full peer set: NGL Fine-Chem Limited and Wockhardt Ltd.

Data source: NSE and company filings via StockeZee. This comparison is informational — it is not investment advice, and StockeZee is not a SEBI-registered investment adviser.